Kadimastem Stock Fundamentals
| KDST Stock | ILA 485.00 35.00 6.73% |
Kadimastem fundamentals help investors to digest information that contributes to Kadimastem's financial success or failures. It also enables traders to predict the movement of Kadimastem Stock. The fundamental analysis module provides a way to measure Kadimastem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kadimastem stock.
Kadimastem |
Kadimastem Company Return On Asset Analysis
Kadimastem's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Kadimastem Return On Asset | -0.75 |
Most of Kadimastem's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kadimastem is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Kadimastem has a Return On Asset of -0.7485. This is 91.45% lower than that of the Biotechnology sector and 96.83% lower than that of the Health Care industry. The return on asset for all Israel stocks is notably higher than that of the company.
Kadimastem Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Kadimastem's current stock value. Our valuation model uses many indicators to compare Kadimastem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kadimastem competition to find correlations between indicators driving Kadimastem's intrinsic value. More Info.Kadimastem is currently regarded as number one stock in return on equity category among related companies. It is currently regarded as number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Kadimastem by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Kadimastem's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kadimastem's earnings, one of the primary drivers of an investment's value.Kadimastem Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kadimastem's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kadimastem could also be used in its relative valuation, which is a method of valuing Kadimastem by comparing valuation metrics of similar companies.Kadimastem is currently under evaluation in return on asset category among related companies.
Kadimastem Fundamentals
| Return On Equity | -7.35 | |||
| Return On Asset | -0.75 | |||
| Current Valuation | 38.77 M | |||
| Shares Outstanding | 35.76 M | |||
| Shares Owned By Insiders | 53.72 % | |||
| Shares Owned By Institutions | 8.31 % | |||
| Price To Earning | (167.60) X | |||
| Price To Book | 5.90 X | |||
| EBITDA | (24.48 M) | |||
| Net Income | (26.27 M) | |||
| Cash And Equivalents | 5.43 M | |||
| Cash Per Share | 0.28 X | |||
| Total Debt | 12.96 M | |||
| Debt To Equity | 7.80 % | |||
| Current Ratio | 0.39 X | |||
| Book Value Per Share | 0.23 X | |||
| Cash Flow From Operations | (21.55 M) | |||
| Earnings Per Share | (1.11) X | |||
| Number Of Employees | 23 | |||
| Beta | 0.69 | |||
| Market Capitalization | 30.32 M | |||
| Total Asset | 27.34 M | |||
| Retained Earnings | (88 M) | |||
| Working Capital | (6 M) | |||
| Current Asset | 5 M | |||
| Current Liabilities | 11 M | |||
| Z Score | -3.0 | |||
| Net Asset | 27.34 M |
About Kadimastem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kadimastem's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kadimastem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kadimastem based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. The company was founded in 2008 and is based in Ness Ziona, Israel. KADIMASTEM operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 28 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Kadimastem in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Kadimastem's short interest history, or implied volatility extrapolated from Kadimastem options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kadimastem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Kadimastem Stock analysis
When running Kadimastem's price analysis, check to measure Kadimastem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kadimastem is operating at the current time. Most of Kadimastem's value examination focuses on studying past and present price action to predict the probability of Kadimastem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kadimastem's price. Additionally, you may evaluate how the addition of Kadimastem to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |